there was an article in today's article recommending a sell on avexa stock.
a line in the article that stood out to me was that apparently there's a group of 20 non-institutional shareholders who are supporting or behind the nominations for the 2 new directors. Apparently this group of 20 shareholder's (some of whom are probably hotcopper members) main aim is to prevent the board shelving ATC.
Has anyone heard anything more about this, and if it has any merit, what are likely outcomes here?
In principle, the main issue in this whole ATC debacle that I am having a hard time grasping is indeed why shelve the drug? Why not cut a less than favourable deal with literally anyone. This would at least have prevented the 75 cut in share price.
Avexa should do a deal with the Bill and Melinda gates foundation to supply avexa to third world african nations (im being sarcastic but my point is im sure someone somewhere wouldve taken atc)
Add to My Watchlist
What is My Watchlist?